April 8, 2019
Neon Therapeutics (NASDAQ:NTGN) has announced it has completed enrollment of NT-002, its Phase 1b clinical trial evaluating NEO-PV-01 with KEYTRUDA...
February 28, 2019
Advancements for breast cancer patients are being led by breast cancer combination therapy innovations, and off-the-shelf personalized immunotherapy
January 3, 2019
Cocrystal Pharma and Merck have announced a new partnership that ignited investor attention in early trading on Thursday.
December 6, 2018
BriaCell Therapeutics Corp. (TSX:BCT, OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a proprietary targeted immunotherapy technology, announces the presentation of...
November 13, 2018
CRISPR Cas-9 gene editing is finally in clinical studies. Here's an overview of CRISPR genetics testing trials currently in progress.
October 14, 2018
A look at 10 drugs going off patent in 2018, plus an overview of what loss of exclusivity means for...
September 20, 2018
Galectin Therapeutics (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, and Providence Cancer Institute today announced additional preliminary clinical data from...